The results demonstrated that tirzepatide significantly reduced serum levels of alanine transaminase (ALT) and aspartate transaminase (AST), as well as hepatic triglycerides (TG) and total cholesterol (TC), indicating its efficacy in treating MAFLD
[1] For medications with narrow therapeutic windows, discuss timing of administration with your healthcare provider
For Zepbound, a synthetic peptide-based prescription medicine approved for chronic weight management, maintaining medication integrity is particularly important given its molecular structure and specific storage requirements
Side Effects Comparison Both medications share similar gastrointestinal side effects as members of the GLP-1 receptor agonist class
21 Several incretin-based therapies, including liraglutide, dulaglutide, semaglutide, and tirzepatide, are currently approved for patients with type 2 diabetes ( Table )
My only critique besides price would be the formatting of the account dashboard